Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

August 26, 2026

Exploring genes and cells at Scientifica 2026

On August 23, the Corn Lab opened its doors as part of Scientifica 2026, inviting young visitors aged 12–16 to explore how scientists study genes and cells ...

July 30, 2026

Welcome to Cian!

Cian received his PhD in Brain and Cognitive Sciences from MIT in January 2026. In July 2026, he joined the Corn lab as a postdoctoral researcher. His research...

July 10, 2026

Making small genome editors more powerful– new paper published in Genome Biology

Genome editing therapies often rely on viral delivery systems such as adeno-associated viruses (AAVs), which have limited cargo capacity. Although RNA-guided...

News Archive

Tweets